MethylGene’s, HDAC Inhibitor, MGCD0103 Selected As A Leading Cancer Project By Windhover Survey

MethylGene Inc. (TSX: MYG) today announced that Donald F. Corcoran, President and Chief Executive Officer of MethylGene, will present at Windhover’s Therapeutics Alliance Oncology Conference in Atlanta at 12:10 p.m., ET on Wednesday, June 7, 2006.